| Issue Date | Title | Author(s) |
| 2023-07-05 | Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus. | Lee, J; Thomas Broome, S; Jansen, MI; Mandwie, M; Logan, GJ; Marzagalli, R; Musumeci, G; Castorina, A |
| 2015-03-13 | Ameliorative effects of PACAP against cartilage degeneration. Morphological, immunohistochemical and biochemical evidence from in vivo and in vitro models of rat osteoarthritis | Giunta, S; Castorina, A; Marzagalli, R; Szychlinska, MA; Pichler, K; Mobasheri, A; Musumeci, G |
| 2015-10-22 | Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme | Musumeci, G; Magro, G; Cardile, V; Coco, M; Marzagalli, R; Castrogiovanni, P; Imbesi, R; Graziano, ACE; Barone, F; Di Rosa, M; Castorina, S; Castorina, A |
| 2015-01-01 | Emerging role of PACAP as a new potential therapeutic target in major diabetes complications | Marzagalli, R; Scuderi, S; Drago, F; Waschek, JA; Castorina, A |
| 2016-03-01 | Genetic blockade of the dopamine D<inf>3</inf> receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution | Marzagalli, R; Leggio, GM; Bucolo, C; Pricoco, E; Keay, KA; Cardile, V; Castorina, S; Salomone, S; Drago, F; Castorina, A |
| 2018-04-01 | Identification of dysregulated microRNA networks in schwann cell-like cultures exposed to immune challenge: Potential crosstalk with the protective VIP/PACAP neuropeptide system | Musumeci, G; Leggio, GM; Marzagalli, R; Al-Badri, G; Drago, F; Castorina, A |
| 2015-06-01 | Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: Is the escape from senescence an answer? | Castorina, A; Szychlinska, MA; Marzagalli, R; Musumeci, G |
| 2015-02-06 | PACAP interacts with PAC<inf>1</inf> receptors to induce tissue plasminogen activator (tPA) expression and activity in Schwann cell-like cultures | Castorina, A; Waschek, JA; Marzagalli, R; Cardile, V; Drago, F |
| 2015-01-01 | The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer’s disease: Agonists or antagonists? | Marzagalli, R; Castorina, A |
| 2018-01-01 | Tackling dipeptidyl peptidase IV in neurological disorders | Al-Badri, G; Leggio, GM; Musumeci, G; Marzagalli, R; Drago, F; Castorina, A |
